INBS
INTELLIGENT BIO SOLUTIONS INC.
$2.45
-0.41%
$5.9M
No data for this timeframe.
Vol
Market Cap$5.9M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$86.00
Reddit Sentiment40° Cool
SEC Reports1
Press Releases1
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001725430·Prev Close $2.46
Recent Activity
Jun 4, 2026
other
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
<p align="justify">NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nas
Jun 2, 2026
SEC
Intelligent Bio Solutions announced the initiation of a multi-site Method Comparison Study to support its FDA 510(k) sub
8-K — Impact 3/10
Apr 20, 2026
Press
Intelligent Bio Solutions (INBS) announced a validation study aimed at reducing its drug screening system's analysis tim
Impact 6/10
Mar 18, 2026
Insider
Fraser Nicola Marion sold 5,000 shares
Director @ $0.00 ($0.00)
Mar 18, 2026
Insider
Isenberg Jason sold 5,000 shares
Director @ $0.00 ($0.00)
Mar 18, 2026
Insider
Hurd Jonathan Scott sold 5,000 shares
Director @ $0.00 ($0.00)
Analyst Ratings
3Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
3/10
Intelligent Bio Solutions announced the initiation of a multi-site Method Comparison Study to support its FDA 510(k) sub
Jun 2, 2026
MIXED
Press
6/10
Intelligent Bio Solutions (INBS) announced a validation study aimed at reducing its drug screening system's analysis tim
Apr 20, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $86.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 18, 2026 | Fraser Nicola | A | $0.00 |
| Mar 18, 2026 | Isenberg Jason | A | $0.00 |
| Mar 18, 2026 | Hurd Jonathan | A | $0.00 |
| Mar 18, 2026 | Simeonidis Harry | A | $0.00 |
| Mar 18, 2026 | Boyages Steven | A | $0.00 |
Reddit Sentiment
40°
Cool
Bearish
Neutral
Bullish
1 institutional holders with $86.00 total value (9 shares) as of 2025-Q4. Top holders: BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 9 | $86.00 | 100.0% | — |
6 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Fraser Nicola Marion | Director | A | 5,000 | $0.00 | $0.00 |
| Mar 18, 2026 | Isenberg Jason | Director | A | 5,000 | $0.00 | $0.00 |
| Mar 18, 2026 | Hurd Jonathan Scott | Director | A | 5,000 | $0.00 | $0.00 |
| Mar 18, 2026 | Simeonidis Harry | Chief Executive Officer | A | 9,150 | $0.00 | $0.00 |
| Mar 18, 2026 | Boyages Steven Constantine | Director | A | 5,000 | $0.00 | $0.00 |
| Mar 18, 2026 | Sakiris Spiro Kevin | Chief Financial Officer | A | 9,150 | $0.00 | $0.00 |
1 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 3.0/10.
Historical analyst distribution: 86% buy across 7 analysts — 3 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jan 1, 2025 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Dec 1, 2024 | 3 | 3 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
40°
Cool
Bearish
Neutral
Bullish
1 mentions
0 bullish
1 bearish
1 time period
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Feb 12, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
Jun 4, 2026
other
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
<p align="justify">NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical te
May 13, 2026
earnings
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
<p align="center"><em>Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66% of quarterly sale
May 11, 2026
short_volume
Short Volume: INBS — 57.7% short (0.3M / 0.5M)
Short: 295,670 | Exempt: 180 | TRF Vol: 512,009 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
fda
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
<p align="center"><em>Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time f
Apr 17, 2026
other
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified
INBS implements enhanced security architecture to protect test integrity and donor data, strengthening upcoming FDA 510(k) submission <pre>INBS implem
Apr 2, 2026
fda
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
<p align="center"><em>Study results finalized on schedule </em><em>support FDA clearance and planned U.S. commercial launch</em></p>